(Q36210870)

12 August 2017

1 reference

title

Application of DNA microarray technology in determining breast cancer prognosis and therapeutic response (English)

1 reference

12 August 2017

5

1 reference

12 August 2017

Aedín C Culhane

4

0 references

William M Gallagher

object named as

William M Gallagher

7

0 references

author name string

Donal J Brennan

1

1 reference

12 August 2017

Sallyann L O'Brien

2

1 reference

12 August 2017

Ailís Fagan

3

1 reference

12 August 2017

Michael J Duffy

6

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

Expert Opinion on Biological Therapy

12 August 2017

1 reference

12 August 2017

5

1 reference

12 August 2017

1069-1083

1 reference

12 August 2017

8

1 reference

Trends in mortality from major cancers in the European Union, including acceding countries, in 2004.

12 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

New data on chemotherapy in the adjuvant setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: inhibition by gefitinib ('Iressa', ZD1839).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Microarray platforms--comparisons and contrasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Microarray technologies 2003 -- an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Navigating gene expression using microarrays--a technology review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Methods and approaches in the analysis of gene expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Cluster analysis and display of genome-wide expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Support vector machine classification and validation of cancer tissue samples using microarray expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Between-group analysis of microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

limmaGUI: a graphical user interface for linear modeling of microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Molecular profiling of breast cancer: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Cross-platform comparison and visualisation of gene expression data using co-inertia analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Gene expression predictors of breast cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Molecular classification of breast cancer patients by gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Gene expression profiling identifies molecular subtypes of inflammatory breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Genes that co-cluster with estrogen receptor alpha in microarray analysis of breast biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Expression profiling to predict outcome in breast cancer: the influence of sample selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Molecular classification of familial non-BRCA1/BRCA2 breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Gene expression profiles in breast tumors regarding the presence or absence of estrogen and progesterone receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Cell-type-specific responses to chemotherapeutics in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Characterization of adjacent breast tumors using oligonucleotide microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Gene expression profiles of primary breast tumors maintained in distant metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Predicting the clinical status of human breast cancer by using gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Identification and validation of an ERBB2 gene expression signature in breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

A molecular signature of metastasis in primary solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Gene expression patterns in ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Importance of orthotopic transplantation procedures in assessing the effects of transfected genes on human tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Outcome signature genes in breast cancer: is there a unique set?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

A study of inter-lab and inter-platform agreement of DNA microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Preoperative/neoadjuvant medical therapy for early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Design of studies using DNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Gene-Expression Profiles in Hereditary Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Prognosis of Breast Cancer and Gene Expression Profiling Using DNA Arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

21 January 2018

The molecular outlook

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.8.1069

10.1517/14712598.5.8.1069

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference